---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-21-000510"
form_type: "8-K"
ticker: "KOD"
cik: "0001468748"
company_name: "Kodiak Sciences Inc."
filed_at: "2021-07-23T23:59:59+00:00"
generated_at: "2026-06-30T02:55:09.823406+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Kodiak Sciences avoids $125M royalty-draw; reduces royalty cap to $450M

## Summary
- Company and BBA agreed not to fund second $125M tranche of royalty financing agreement.
- Royalty cap reduced from $1,012.5M to $450M (4.5x the $100M already funded).
- Decision driven by strong balance sheet after $612M capital raise in Nov 2020 and clinical progress.
- Independent board committee ratified the decision.

## SEC filing metadata
- accession: 0000950170-21-000510
- form_type: 8-K
- ticker: KOD
- cik: 0001468748
- company_name: Kodiak Sciences Inc.
- filed_at: 2021-07-23T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468748/000095017021000510/0000950170-21-000510-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468748/000095017021000510/kod-20210721.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-21-000510
- JSON: https://secwatch.observer/filing/0000950170-21-000510.json
- Plain text: https://secwatch.observer/filing/0000950170-21-000510.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.